Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

7 projects found matching your search criteria :

  1. Zinc level and alterations in genes involved in zinc metabolism as risk factors for common cancers in Polish population.

    Call: PRELUDIUM 4 , Panel: NZ4

    Principal investigator: Katarzyna Kaczmarek

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarsko-Biotechnologiczny i Medycyny Laboratoryjnej

  2. Selenium level and selenoprotein gene alterations as risk factors of cancers in Poland.

    Call: PRELUDIUM 2 , Panel: NZ2

    Principal investigator: dr Katarzyna Jaworska-Bieniek

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Lekarsko-Biotechnologiczny i Medycyny Laboratoryjnej

  3. Glucocorticoid-induced alterations of astrocytic metabolism in stress-related disorders.

    Call: OPUS 2 , Panel: NZ3

    Principal investigator: dr Michał Ślęzak

    Instytut Farmakologii PAN

  4. Mitochondria in activated pancreatic stellate cells – the engines of fibrosis? Alterations in mitochondria of pancreatic...

    Call: PRELUDIUM 20 , Panel: NZ3

    Principal investigator: Agnieszka Kusiak

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  5. Size matters: How a blastocyst's size affects offspring health

    Call: OPUS 21 , Panel: NZ3

    Principal investigator: prof. Grażyna Ptak

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  6. Application of targeted metabolomic approach in quantitative prospective analysis of nucleosides profiles alterations be...

    Call: PRELUDIUM 15 , Panel: NZ7

    Principal investigator: Małgorzata Artymowicz

    Gdański Uniwersytet Medyczny, Wydział Farmacutyczny

  7. The alterations of lipid metabolism in colorectal cancer - their role in the development of disease and the asessment of...

    Call: SONATA BIS 6 , Panel: NZ4

    Principal investigator: dr hab. Tomasz Śledziński

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny